首页> 外文期刊>Journal of the American Veterinary Medical Association >Comparison of oral and subcutaneous administration of buprenorphine and meloxicam for preemptive analgesia in cats undergoing ovariohysterectomy
【24h】

Comparison of oral and subcutaneous administration of buprenorphine and meloxicam for preemptive analgesia in cats undergoing ovariohysterectomy

机译:丁丙诺啡与美洛昔康口服和皮下给药对卵巢子宫切除术猫先发性镇痛的比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To compare the effectiveness of preoperative PO and SC administration of buprenorphine and meloxicam for prevention of postoperative pain-associated behaviors in cats undergoing ovariohysterectomy. DESIGN: Randomized controlled study. ANIMALS: 51 female cats (4 to 60 months old; weight range, 1.41 to 4.73 kg [3.1 to 10.4 lb]). PROCEDURE: Cats received 1 of 5 treatments at the time of anesthetic induction: buprenorphine PO (0.01 mg/kg [0.0045 mg/lb]; n = 10), buprenorphine SC (0.01 mg/kg; 10), meloxicam SC (0.3 mg/kg 10.14 mg/lb]; 10), meloxicam PO (0.3 mg/kg; 10), or 0.3 mL of sterile saline (0.9% NaCI) solution SC (control group; 11). Sedation scores and visual analog scale and interactive visual analog scale (IVAS) pain-associated behavior scores were assigned to each cat 2 hours before and at intervals until 20 hours after surgery. RESULTS: Cats receiving meloxicam PO or SC had significantly lower IVAS scores (2.91 and 2.02, respectively), compared with IVAS scores for cats receiving buprenorphine PO (755). Pain-associated behavior scores for cats administered buprenorphine or meloxicam PO or SC preoperatively did not differ significantly from control group scores. Rescue analgesia was not required by any of the cats receiving meloxicam, whereas 3 of 10 cats receiving buprenorphine PO, 2 of 10 cats receiving buprenorphine SC, and 1 of 11 cats receiving the control treatment required rescue analgesia. CONCLUSIONS AND CLINICAL RELEVANCE: On the basis of pain-associated behavior scores, cats receiving meloxicam PO or SC before ovariohysterectomy appeared to have less pain after surgery than those receiving buprenorphine PO preoperatively.
机译:目的:比较术前PO和SC联合丁丙诺啡和美洛昔康预防卵巢子宫切除术猫术后疼痛相关行为的有效性。设计:随机对照研究。动物:51只母猫(4至60个月大;体重范围为1.41至4.73千克[3.1至10.4磅])。程序:麻醉诱导时,猫接受5种治疗中的1种:丁丙诺啡PO(0.01 mg / kg [0.0045 mg / lb]; n = 10),丁丙诺啡SC(0.01 mg / kg; 10),美洛昔康SC(0.3 mg / kg 10.14 mg / lb]; 10),美洛昔康PO(0.3 mg / kg; 10)或0.3 mL无菌盐水(0.9%NaCl)溶液SC(对照组; 11)。在手术前2小时和手术后20小时,分别给每只猫分配镇静评分,视觉模拟量表和交互式视觉模拟量表(IVAS)疼痛相关行为评分。结果:与接受丁丙诺啡PO的猫的IVAS评分相比,接受美洛昔康PO或SC的猫的IVAS评分显着较低(分别为2.91和2.02)(755)。术前给予丁丙诺啡或美洛昔康PO或SC的猫与疼痛相关的行为评分与对照组的评分无明显差异。任何接受美洛昔康的猫都不需要镇痛,而接受丁丙诺啡PO的10只猫中有3只,接受丁丙诺啡SC的10只猫中有2只,接受对照治疗的11只猫中的1只需要抢救镇痛。结论和临床意义:根据疼痛相关的行为评分,在接受卵巢子宫切除术之前接受美洛昔康PO或SC的猫手术后疼痛似乎比术前接受丁丙诺啡PO的猫减轻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号